COPD News Today Home | COPD News Today
Nov 19, 2024 · Click the link below to find all of the latest news related to COPD. COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath. The causes of COPD are not fully understood.
New Advances in Managing COPD | TIME
Mar 18, 2024 · From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing.
COPD News - ScienceDaily
5 days ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
Chronic obstructive pulmonary disease - Latest research and news …
Dec 30, 2024 · Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue.
Top 10 COPD stories of 2024 - Healio
Dec 22, 2024 · Here are Healio’s top 10 most-read stories on COPD from 2024. Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe...
COPD: Early Disease May Be Linked to Impaired FEV1/FVC …
1 day ago · Individuals with early-onset chronic obstructive pulmonary disease (COPD) and rapidly progressive pre-COPD frequently have a decades-long history of wheeze and an impaired lung function trajectory, according to study findings published in The Lancet Respiratory Medicine.. Researchers assessed whether individuals with an impaired long-term trajectory of forced expiratory volume in 1 second to ...
Dupixent found to prevent COPD exacerbations in Phase 3 trial
Apr 3, 2023 · Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations and to improve lung function in people with chronic obstructive pulmonary disease (COPD), meeting the primary and key secondary goals of the pivotal Phase 3 BOREAS trial.
News Archives - COPD News Today
KT-621, potential oral medication for COPD, cleared for human trials. The U.S. Food and Drug Administration has cleared the start of clinical trial testing of KT-621, Kymera Therapeutics’ oral therapy for chronic obstructive pulmonary disease (COPD) and other diseases marked by type 2 …
News - COPD.net
Discover COPD content on News as well as categories such as living with COPD, coping with COPD, recent news, clinical, expert opinions, and more. page 1 of 1
News on chronic obstructive pulmonary disease - Medical Xpress
Jan 3, 2025 · Find all the latest on chronic obstructive pulmonary disease at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.